Divis Laboratories Ltd

DIVISLAB
NSE· Healthcare
Market Cap
Volume
Prev Close
ISIN
INE361B01024

VestAI Stock Score

VALUATION
Low Debt
D/E 0.01x — lean balance sheet
QUALITY
Average
ROCE 16.6% — decent returns
MOMENTUM
Bearish
RSI 43.9 — weak momentum

Price Chart

Key Fundamentals

Q3 FY2026

EPS (Qtrly)
₹23.33
OPM
29.65%
ROCE
16.61%
D/E Ratio
0.01x
Qtrly Sales
₹2,604.00 Cr
Qtrly Profit
₹583.00 Cr

Unlock with Pro

Upgrade →

Technical Signals

Unlock with Pro

Upgrade →

Shareholding Pattern

Q4 FY2026

Promoter
52.07%
FII
15.86%
DII
12.97%
Public
19.1%

Unlock with Pro

Upgrade →

Corporate Actions

Unlock with Pro

Upgrade →

Smart Money Holdings

Max Feature

Upgrade to unlock this section

View Plans

Analyse DIVISLAB with Orion AI

Ask: "Is Divis Laboratories Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Divis Laboratories Ltd (DIVISLAB) Stock

Divis Laboratories Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE361B01024. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.